Cargando…
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
Although hyperlipidemia is common in COPD, its relationship to comorbidities, risk factors and lung function in COPD has not been studied in detail. Using the baseline data of the COSYCONET cohort we addressed this question. Data from 1746 COPD patients (GOLD stage 1–4; mean age 64.6 y, mean FEV1%pr...
Autores principales: | Kahnert, Kathrin, Lucke, Tanja, Huber, Rudolf M., Behr, Jürgen, Biertz, Frank, Vogt, Anja, Watz, Henrik, Alter, Peter, Fähndrich, Sebastian, Bals, Robert, Holle, Rolf, Karrasch, Stefan, Söhler, Sandra, Wacker, Margarethe, Ficker, Joachim H., Parhofer, Klaus G., Vogelmeier, Claus, Jörres, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432186/ https://www.ncbi.nlm.nih.gov/pubmed/28505167 http://dx.doi.org/10.1371/journal.pone.0177501 |
Ejemplares similares
-
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017) -
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019) -
Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019) -
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018) -
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)